Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar

Adeel A. Butt, Mylai D. Guerrero,Elenor B. Canlas,Husni Al-Dwairi, Abeir Bakhiet Mohammed Ali Alimam, Abdur Rehman Mohamad, Mohammed Thamer Ali,Nidal Ahmad Asaad,Ali Ahmed Sheikh Saleh Alkeldi, Mohammad Fawaz Saber Mohammad,Anil G. Thomas,Abdullatif Al-Khal,Muna Al-Maslamani,Abdul-Badi Abou-Samra

Nature communications(2023)

Cited 4|Views11
No score
Abstract
Accurate determination of mortality attributable to SARS-CoV-2 vaccination is critical in allaying concerns about their safety. We reviewed every death in Qatar that occurred within 30 days of any SARS-CoV-2 vaccine administration between January 1, 2021 and June 12, 2022. Probability of association with SARS-CoV-2 vaccination was determined by four independent trained reviewers using a modified WHO algorithm. Among 6,928,359 doses administered, 138 deaths occurred within 30 days of vaccination; eight had a high probability (1.15/1,000,000 doses), 15 had intermediate probability (2.38/1,000,000 doses), and 112 had low probability or no association with vaccination. The death rate among those with high probability of relationship to SARS-CoV-2 vaccination was 0.34/100,000 unique vaccine recipients, while death rate among those with either high or intermediate probability of relationship to SARS-CoV-2 vaccination was 0.98/100,000 unique vaccine recipients. In conclusion, deaths attributable to SARS-CoV-2 vaccination are extremely rare and lower than the overall crude mortality rate in Qatar.
More
Translated text
Key words
vaccine,qatar,mortality,sars-cov
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined